Press release
Transplant Diagnostics Market to Surpass US$ 17.2 Bn by 2035 with CAGR of 7.3% Fueled by Organ Transplant Surge and Technological Innovations
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20225
Analysts' Viewpoint
The transplant diagnostics industry is undergoing a fundamental transformation powered by cutting-edge technologies like next-generation sequencing (NGS), machine learning, and circulating cell-free DNA (cfDNA) monitoring. Rising incidence of chronic diseases, aging populations, and supportive government policies worldwide are contributing to the growing demand for advanced diagnostic systems that ensure precise donor-recipient compatibility and improve transplant success rates.
Innovations in molecular assay techniques, along with the surge in organ donation campaigns, have further propelled industry growth. Leading players are investing in AI-integrated diagnostic solutions, creating a robust ecosystem for precision transplant care.
Market Overview
Transplant diagnostics encompasses a suite of technologies used to assess donor-recipient compatibility, detect immune responses, and monitor post-transplant health. These tools are essential for organ, tissue, and stem cell transplants, ensuring optimal matching and minimizing the risk of rejection.
HLA typing, genomic profiling, and biomarker identification are integral techniques that support the decision-making process before and after transplantation. Innovations in non-invasive diagnostics, such as cfDNA tests, enable continuous monitoring of graft health without biopsies.
Key Market Drivers
Rising Incidence of Organ Transplants
The number of global organ transplant procedures is steadily rising. In the U.S. alone, 48,149 organ transplants were performed in 2024-a 3.3% increase from the previous year. With increasing incidence of organ failure due to chronic conditions like kidney disease, liver cirrhosis, and cardiac disorders, demand for transplant-compatible diagnostics is at an all-time high.
Advanced technologies are being rapidly integrated into hospital labs and transplant centers to ensure better organ matching and post-operative success.
Growing Awareness and Acceptance of Organ Donation
Public and private campaigns have significantly raised awareness about organ donation, leading to an expanding donor pool. Initiatives led by government agencies, NGOs, and health influencers have normalized conversations about organ donation and fostered a cultural shift. This surge in donor availability requires precise diagnostics to ensure transplant suitability, boosting demand for molecular and immunological testing kits.
Digital health tools and social media platforms are amplifying organ donation campaigns and encouraging real-time testimonials from transplant recipients, further fueling market awareness.
Segment Insights
By Product & Service
Kits & Reagents dominate the market due to their integral role in HLA typing and antibody detection. Their widespread usage in hospitals and research labs makes them the backbone of transplant diagnostics.
Instruments and Software & Services are growing steadily as automation and AI integration become standard in diagnostic workflows.
By Technique
Molecular Assays lead the segment with advanced platforms like PCR and NGS, offering highly sensitive results and detailed genetic information crucial for transplant matching.
Non-Molecular Assays, including serological tests, remain important for basic screening but are increasingly complemented by molecular technologies.
By Transplant Type
Organ Transplants (Kidney, Liver, Heart, Lung) account for the largest share, driven by rising chronic illnesses and the availability of high-end diagnostic tools.
Tissue Transplants (Corneal, Skin, Bone) and Stem Cell Transplants are growing areas with increased research and clinical focus.
By Screening Type
Pre-transplant Diagnostics dominate due to the criticality of donor-recipient matching before procedures.
Post-transplant Diagnostics are gaining traction with innovations like cfDNA-based graft monitoring and early rejection detection tools.
Regional Outlook
North America led the transplant diagnostics market in 2024, accounting for the largest revenue share. Key factors include:
Advanced healthcare infrastructure
Strong presence of top diagnostics companies
Government support for organ donation programs
Higher prevalence of chronic and end-stage diseases
The U.S. dominates regional growth with robust transplant networks, strict regulatory oversight, and rapid adoption of AI-enabled diagnostics.
Asia Pacific is anticipated to witness the fastest CAGR through 2035 due to:
Rising awareness and transplant programs in India and China
Government initiatives to promote healthcare access
Emerging private-sector investments in medical diagnostics
Competitive Landscape
Leading players are expanding their product portfolios, engaging in strategic partnerships, and advancing automation to offer comprehensive transplant testing platforms.
Key Players
Abbott
Thermo Fisher Scientific, Inc.
QIAGEN N.V.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Illumina, Inc.
Siemens Healthineers
bioMérieux
Bruker Corporation
Agilent Technologies, Inc.
Hologic, Inc.
Takara Bio Inc.
Werfen, S.A.
DiaSorin S.p.A.
QuidelOrtho Corporation
Recent Developments
October 2024 - QIAGEN upgraded its EZ2 Connect platform for non-invasive liquid biopsy in transplant, oncology, and prenatal diagnostics, allowing high-throughput sample processing and precision ccfDNA isolation.
July 2024 - Thermo Fisher Scientific launched a CLIA-certified pre-transplant risk assessment assay, aimed at predicting acute rejection in kidney transplant patients, enabling tailored immunosuppressive therapy post-surgery.
Market Segmentation
By Product & Service
Instruments
Kits and Reagents
Software and Services
By Technique
Molecular Assay
Non-molecular Assay
By Transplant Type
Organ Transplant (Kidney, Liver, Heart, Lung, Others)
Tissue Transplant (Corneal, Skin, Bone, Cartilage, Others)
Stem Cell Transplant
By Screening Type
Pre-Transplant Diagnostics
Post-Transplant Diagnostics
By End-user
Hospitals
Transplant Centers
Research Laboratories
Others
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=20225<ype=S
Explore Latest Research Reports by Transparency Market Research:
Vaginal Pessaries Market- https://www.transparencymarketresearch.com/vaginal-pessaries-market-report.html
Drug-device Combination Products Market- https://www.transparencymarketresearch.com/drug-device-combination.html
U.S., Europe, and Japan Adhesion Barriers Market- https://www.transparencymarketresearch.com/u.s-europe-and-japan-adhesion-barriers-market.html
Atraumatic Needles Market- https://www.transparencymarketresearch.com/atraumatic-needles-market.html
Shoulder Replacement Market- https://www.transparencymarketresearch.com/shoulder-replacement-market.html
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transplant Diagnostics Market to Surpass US$ 17.2 Bn by 2035 with CAGR of 7.3% Fueled by Organ Transplant Surge and Technological Innovations here
News-ID: 4099910 • Views: …
More Releases from Transparency Market Research
Facial Injectables Market to Surpass US$ 27.0 Billion by 2035 Fueled by Non-surg …
The global facial injectables market was valued at US$ 10.3 Bn in 2024 and is expected to reach US$ 27.0 Bn by 2035, expanding at a CAGR of 9.2% from 2025 to 2035, according to a market intelligence report published by Transparency Market Research Inc. Rising preference for non-invasive aesthetic treatments, aging population, and growing male interest in cosmetic enhancements are key contributors to the rapid market growth.
Get Sample PDF…
Coronary Stents Market to Cross US$ 12.8 Bn by 2035 Driven by Minimally Invasive …
The global coronary stents market was valued at US$ 7,222.5 Mn in 2024 and is projected to expand at a CAGR of 5.3% from 2025 to 2035, reaching US$ 12,846.6 Mn by 2035, according to a new market outlook by Transparency Market Research. Market growth is fueled by increasing prevalence of coronary artery disease (CAD), rising preference for minimally invasive procedures, and favorable reimbursement frameworks across key healthcare economies.
Get Sample…
Smart Insulin Pens & Pumps Market Forecast 2035: Digital Diabetes Management and …
The global Smart Insulin Pens & Pumps Market is poised for significant transformation, driven by rising diabetes prevalence and the pressing demand for personalized, efficient, and user-friendly insulin delivery solutions. Valued at US$ 6.1 Bn in 2024, the market is projected to grow at a CAGR of 8.5% from 2025 to 2035, surpassing US$ 14.6 Bn by the end of 2035. As healthcare increasingly adopts patient-centric approaches and connected medical…
Middle East and Africa Infusion Pump Market to Surpass USD 850.1 Million by 2035 …
The Middle East and Africa (MEA) Infusion Pump Market, valued at US$ 413.2 million in 2024, is poised for significant growth over the next decade. According to recent market analysis, the sector is projected to expand at a CAGR of 6.7% from 2025 to 2035, reaching US$ 850.1 million by the end of the forecast period. The uptick in chronic diseases, technological innovations, and rising healthcare investments are accelerating the…
More Releases for Transplant
Global Tacrolimus Injection Market Size, Share & Trends Analysis Report, By Appl …
The global tacrolimus injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tacrolimus, also known as Prograf, is an immunosuppressive drug primarily used with other medications to prevent rejection of a heart, kidney, or liver transplant in adult and pediatric patients. This medication works by supporting the body to accept the new organ and lower the risk of organ rejection so as to prevent…
Organ Transplant Market | Organogenesis Incorporated, Terumo Co., OrganOX, Trans …
Organ Transplant Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of the world Organ Transplant Market.
Organ Transplant Market report provides emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective…
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant.
Major Players:
The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
hair transplant services
Hair transplant is a surgical procedures that moves hair follicles from one part of the body to another part of the body. Hair transplantation is chiefly used to treat the baldness in male and female.
The global hair transplant services market is witnessing a rise in its demand. The market is segmented into three major transplant procedures like scalp reduction, follicular unit strip surgery and follicular unit extraction.
Increasing importance regarding…
Organ Transplant Immunosuppressant Drugs Market By Drug Class, By Transplant, By …
This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow. Organ dysfunction caused due to severe injuries, cancer, organ failure and/or genetic disorders necessitate the requirement for organ transplant procedures. Thus, rise in the number of…
